PFA Pension, Forsikringsaktieselskab
PensionPosition in EXEL — Exelixis, Inc.
CIK 1730073
COPENHAGEN, G7
Position in EXEL
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,914,695
+$1,165 QoQ
Shares Held
44,642
+2.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PFA Pension, Forsikringsaktieselskab holds $229,879,451 across 8 Biotechnology names. EXEL ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
92,856 | $71,744,259 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
134,996 | $60,281,113 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,118,911 | $53,674,160 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
59,700 | $19,752,939 | |
| 5 | INSM |
INSMED Inc
|
114,788 | $18,770,133 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
44,642 | $1,914,695 | |
| 7 | INCY |
Incyte Corp
|
19,900 | $1,872,988 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
28,921 | $1,869,164 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,914,695 | 44,642 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,913,530 | 43,658 | Shares | Sole | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||